Spasticity in multiple sclerosis and role of glatiramer acetate treatment-Reference-Cited by-同舟云学术

Spasticity in multiple sclerosis and role of glatiramer acetate treatment

Published:2015-07-14 Issue:9 Volume:5 Page:
ISSN:2162-3279
Container-title:Brain and Behavior
language:en
Short-container-title:Brain Behav

Author:

Meca‐Lallana Jose Eustasio¹²,Hernández‐Clares Rocío¹²,Carreón‐Guarnizo Ester¹²

Affiliation:

1. Department of Neurology Multiple Sclerosis Unit Hospital Clínico Universitario Virgen de la Arrixaca Carretera Madrid‐Cartagena s/n 30120 Murcia Spain

2. Cátedra de Neuroinmunología Clínica y Esclerosis Múltiple UCAM Universidad Católica San Antonio de Murcia Campus de los Jerónimos Guadalupe 30107 Murcia Spain

Publisher

Wiley

Subject

Behavioral Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.367

Reference93 articles.

1. Generalized Myoclonus and Spasticity Induced by Lamotrigine Toxicity

2. Non pharmacological interventions for spasticity in multiple sclerosis;Amatya B.;Cochrane Database Syst. Rev.,2013

3. Ashworth Scales are unreliable for the assessment of muscle spasticity

4. The interrater and intrarater reliability of the Modified Ashworth Scale in the assessment of muscle spasticity: limb and muscle group effect;Ansari N. N.;NeuroRehabilitation,2008

5. Inter‐rater reliability of the Modified Modified Ashworth Scale as a clinical tool in measurements of post‐stroke elbow flexor spasticity;Ansari N. N.;NeuroRehabilitation,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Levetiracetam on the Treatment of Spasticity in Neurologic Disorders: a Systematic Review;SN Comprehensive Clinical Medicine;2023-08-23

2. Nociceptive and Mixed Pain Syndromes in Patients with Multiple Sclerosis;Neuroscience and Behavioral Physiology;2023-03

3. Serie de 46 pacientes con paraparesia espástica. Presentación clínica y dificultades diagnósticas;Neurología Argentina;2022-01

4. Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms—A Narrative Review;Neurology and Therapy;2021-04-20

5. Possible Influence of the Route of Treatment Administration on Treatment Adherence in Patients With Multiple Sclerosis;Clinical Therapeutics;2020-05